Back

Safety and efficacy of ultra-long intermediate-power ablation for outflow tract ventricular arrhythmia arising from the left ventricular summit

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Tips and tricks in catheter ablation of ventricular arrhythmias Ablation of Ventricular Arrhythmias ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Pragyat Futela

Metrohealth Medical Center, Cleveland (United States of America)

5 More presentations in this session

Presentation thumbnail
Vector field heterogeneity as a novel omnipolar mapping metric for functional substrate characterization in scar-related ventricular tachycardias
Doctor J. Tonko (London, GB)
Abstract Slides
Presentation thumbnail
Accuracy of endocardial abnormal electrogram characterization using a 17-AHA-segmental late boundary and voltage-dependent sensitivity annotation for ventricular tachycardia ablation
Miss Y. Kaya (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Epicardial ablation in patients with Brugada syndrome: a single centre experience
Doctor A. Rafaj (Prague, CZ)
Abstract Slides
Presentation thumbnail
Vector Field Heterogeneity (VFH) as a novel quantitative marker of electrical disarray in Arrhythmogenic CardioMyopathy (ACM) with ventricular tachycardia
Doctor J. Tonko (London, GB)
Abstract Slides
Presentation thumbnail
Outcomes of ventricular tachycardia ablation with intracardiac echocardiography-a retrospective cohort study of the national inpatient sample
Professor J. Hsu (La Jolla, US)
Abstract Slides Video

Access the full session

Session thumbnail
Tips and tricks in catheter ablation of ventricular arrhythmias

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources